Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 423

    1.

    Patient satisfaction and glycemic control after 1 year with inhaled insulin (Exubera) in patients with type 1 or type 2 diabetes.

    Rosenstock J, Cappelleri JC, Bolinder B, Gerber RA.

    Diabetes Care. 2004 Jun;27(6):1318-23.PMID: 15161782 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Treatment satisfaction in type 2 diabetes: a comparison between an inhaled insulin regimen and a subcutaneous insulin regimen.

    Cappelleri JC, Cefalu WT, Rosenstock J, Kourides IA, Gerber RA.

    Clin Ther. 2002 Apr;24(4):552-64.PMID: 12017400 [PubMed - indexed for MEDLINE]Related articles

    3.

    Treatment satisfaction with inhaled insulin in patients with type 1 diabetes: a randomized controlled trial.

    Gerber RA, Cappelleri JC, Kourides IA, Gelfand RA.

    Diabetes Care. 2001 Sep;24(9):1556-9.PMID: 11522698 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial.

    Quattrin T, Bélanger A, Bohannon NJ, Schwartz SL; Exubera Phase III Study Group.

    Diabetes Care. 2004 Nov;27(11):2622-7.PMID: 15504996 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes: a randomized, controlled trial.

    Rosenstock J, Zinman B, Murphy LJ, Clement SC, Moore P, Bowering CK, Hendler R, Lan SP, Cefalu WT.

    Ann Intern Med. 2005 Oct 18;143(8):549-58.PMID: 16230721 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Meta-analysis: efficacy and safety of inhaled insulin therapy in adults with diabetes mellitus.

    Ceglia L, Lau J, Pittas AG.

    Ann Intern Med. 2006 Nov 7;145(9):665-75.PMID: 17088580 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Intensive therapy with inhaled insulin via the AERx insulin diabetes management system: a 12-week proof-of-concept trial in patients with type 2 diabetes.

    Hermansen K, Rönnemaa T, Petersen AH, Bellaire S, Adamson U.

    Diabetes Care. 2004 Jan;27(1):162-7.PMID: 14693983 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Effect of inhaled insulin on patient-reported outcomes and treatment preference in patients with type 1 diabetes.

    Hayes RP, Muchmore D, Schmitke J.

    Curr Med Res Opin. 2007 Feb;23(2):435-42.PMID: 17288697 [PubMed - indexed for MEDLINE]Related articles

    10.

    Antibody response to inhaled insulin in patients with type 1 or type 2 diabetes. An analysis of initial phase II and III inhaled insulin (Exubera) trials and a two-year extension trial.

    Fineberg SE, Kawabata T, Finco-Kent D, Liu C, Krasner A.

    J Clin Endocrinol Metab. 2005 Jun;90(6):3287-94. Epub 2005 Mar 1.PMID: 15741258 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Improved glycemic control with use of continuous subcutaneous insulin infusion compared with multiple insulin injection therapy.

    Bell DS, Ovalle F.

    Endocr Pract. 2000 Sep-Oct;6(5):357-60.PMID: 11141585 [PubMed - indexed for MEDLINE]Related articles

    13.

    Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.

    Esposito K, Ciotola M, Maiorino MI, Gualdiero R, Schisano B, Ceriello A, Beneduce F, Feola G, Giugliano D.

    Ann Intern Med. 2008 Oct 21;149(8):531-9.PMID: 18936501 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Preferences of patients with diabetes mellitus for inhaled versus injectable insulin regimens.

    Chancellor J, Aballéa S, Lawrence A, Sheldon R, Cure S, Plun-Favreau J, Marchant N.

    Pharmacoeconomics. 2008;26(3):217-34.PMID: 18282016 [PubMed - indexed for MEDLINE]Related articles

    16.

    Inhaled human insulin.

    Strack TR.

    Drugs Today (Barc). 2006 Apr;42(4):207-21. Review.PMID: 16703118 [PubMed - indexed for MEDLINE]Related articles

    17.

    Satisfaction and quality of life with premeal inhaled versus injected insulin in adolescents and adults with type 1 diabetes.

    Testa MA, Simonson DC.

    Diabetes Care. 2007 Jun;30(6):1399-405. Epub 2007 Mar 2.PMID: 17337493 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    The effect of the availability of inhaled insulin on glycaemic control in patients with Type 2 diabetes failing on oral therapy: the evaluation of Exubera as a therapeutic option on insulin initiation and improvement in glycaemic control in clinical practice (EXPERIENCE) trial.

    Del Prato S, Blonde L, Martinez L, Göke B, Woo V, Millward A, Gomis R, Canovatchel B, Strack T, Lawrence D, Freemantle N; EXPERIENCE Trial Team.

    Diabet Med. 2008 Jun;25(6):662-70. Epub 2008 Apr 23.PMID: 18435781 [PubMed - indexed for MEDLINE]Related articles

    19.

    Continuous subcutaneous insulin infusion attenuated glycemic instability in preschool children with type 1 diabetes mellitus.

    Alemzadeh R, Palma-Sisto P, Holzum M, Parton E, Kicher J.

    Diabetes Technol Ther. 2007 Aug;9(4):339-47.PMID: 17705689 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data